Find out how we provided our client with a clear and effective path forward to help launch their pre-filled syringes for subcutaneous immunoglobulin therapy, and how best to position themselves for widespread adoption.

In the first blog of our PMCF Insights Series, Hemant Mistry and Matthew Hanson explore different types of bias in medical device research, the measures being taken to address these issues, and how Purdie Pascoe's deep expertise helps eliminate bias in PMCF surveys.

A leading medical device manufacturer required Post Market Clinical Follow-Up (PMCF) data for their legacy Class I syringe. This clinical evidence was needed to comply with PMCF data collection under the EU-MDR. Find out how our PMRC survey approach strengthened the regulatory compliance for their device.

Marcus Torr provides about his perspective about the importance of PMCF Survey implementation for medical device EU-MDR submissions. He reveals why medical device manufacturers should consider PMCF surveys, how to overcome challenges, solutions for a best practice approach and what makes Purdie Pascoe’s specialist expertise unique.

In this episode Podymos interviewed Purdie Pascoe MedTech experts Sabera Hyderally and Guy Pascoe, who takes us on a journey through the product lifecycle and how market research can significantly increase market adoption, and boost your marketing strategy.

In this episode Purdie Pascoe MedTech experts Sabera Hyderally and Guy Pascoe were interviewed by Podymos to reveal integral insights regarding the importance of market research, specifically for medical devices, to boost your marketing strategy and achieve actionable results.

PMCF is an essential aspect of medical device regulation. In this interview Marcus Torr provides a breakdown of the best approach, including how it can improve patient safety as well as the challenges it poses for small to medium-sized enterprises.

In the 1990s, when I started in healthcare market research, successful pharma launches were built on strong clinical profiles. Blockbusters like Lipitor, Prozac and Losec succeeded on the basis of their superior clinical data. Huge salesforces then took this data to as many doctors as possible to persuade them of the value of their product…and huge sales followed.